Content about Budesonide

January 16, 2013

FDA approves Uceris for ulcerative colitis

The Food and Drug Administration has approved an ulcerative colitis drug made by Santarus, the drug maker said.

SAN DIEGO — The Food and Drug Administration has approved an ulcerative colitis drug made by Santarus, the drug maker said.

Santarus announced the approval of Uceris (budesonide) extended-release tablets for mild to active UC. The company plans to launch the drug in March.

August 1, 2012

FDA approves Watson asthma generic

The Food and Drug Administration has approved a generic drug designed to treat asthma in children.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug designed to treat asthma in children.

Watson Pharmaceuticals announced Wednesday the approval of budesonide inhalation suspension in the 0.25-mg/2-mL and 0.5-mg/2-mL strengths. The drug is used to control and prevent asthma symptoms in children ages 12 months to 8 years.

The drug is a generic version of AstraZeneca's Pulmicort Respules, which had sales of $1.1 billion during the 12-month period ended in May.

November 14, 2010

Study: Mild asthma patients may be overusing drug combinations

Most patients with mild persistent asthma overuse a drug combination despite an apparent lack of...

PHOENIX — Most patients with mild persistent asthma overuse a drug combination despite an apparent lack of added medical benefit, according to a new study by pharmacy benefit manager Medco.

May 17, 2010

AstraZeneca allows Teva to market generic Entocort EC

Teva Pharmaceutical Industries and AstraZeneca have reached a settlement that will allow Teva to market...